Sign up to save your podcasts
Or
Share Incretin-Based Advances in Obesity and T2D Care
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Incretin-Based Advances in Obesity and T2D Care
Guest: Javier Morales, MD, FACP, FACE
For patients with obesity and type 2 diabetes (T2D), emerging incretin-based therapies that target multiple metabolic pathways are producing meaningful weight-loss outcomes. To learn more about these care strategies, tune in as Dr. Javier Morales shares key updates from the 2026 American Diabetes Association Scientific Sessions. Dr. Morales is an Associate Clinical Professor of Medicine at the Barbara and Donald Zucker School of Medicine at Hofstra University and Northwell Health.
View all episodes
By ReachMD
4.3
77 ratings
Guest: Javier Morales, MD, FACP, FACE
For patients with obesity and type 2 diabetes (T2D), emerging incretin-based therapies that target multiple metabolic pathways are producing meaningful weight-loss outcomes. To learn more about these care strategies, tune in as Dr. Javier Morales shares key updates from the 2026 American Diabetes Association Scientific Sessions. Dr. Morales is an Associate Clinical Professor of Medicine at the Barbara and Donald Zucker School of Medicine at Hofstra University and Northwell Health.